Compare CMPR & HTFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CMPR | HTFL |
|---|---|---|
| Founded | 1994 | 2007 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Publishing | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.2B |
| IPO Year | 2005 | 2025 |
| Metric | CMPR | HTFL |
|---|---|---|
| Price | $88.86 | $46.80 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | ★ $86.50 | $38.20 |
| AVG Volume (30 Days) | 193.1K | ★ 1.8M |
| Earning Date | 04-29-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 553.45 | 82.37 |
| EPS | ★ 3.79 | N/A |
| Revenue | ★ $3,736,643,000.00 | $176,034,000.00 |
| Revenue This Year | $10.43 | $27.66 |
| Revenue Next Year | $5.46 | $23.55 |
| P/E Ratio | $23.78 | ★ N/A |
| Revenue Growth | 9.80 | ★ 39.92 |
| 52 Week Low | $56.34 | $20.13 |
| 52 Week High | $106.58 | $47.23 |
| Indicator | CMPR | HTFL |
|---|---|---|
| Relative Strength Index (RSI) | 37.46 | 86.92 |
| Support Level | $88.26 | $24.59 |
| Resistance Level | $105.61 | N/A |
| Average True Range (ATR) | 4.14 | 2.27 |
| MACD | -1.08 | 2.26 |
| Stochastic Oscillator | 9.56 | 96.83 |
Cimpress PLC invests in and builds customer-focused, entrepreneurial, mass-customization businesses for the long term. Mass customization seeks to produce goods and services to meet individual customer needs with near mass production efficiency. Its products and services include a broad range of marketing materials, business cards, signage, promotional products, logo apparel, packaging, books and magazines, wall decor, photo merchandise, invitations and announcements, design and digital marketing services, and other categories. The company's segment includes Vista; PrintBrothers; The Print Group; National Pen and All Other Businesses. It generates maximum revenue from the Vista segment.
HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.